Table 2.
Multivariate Cox regression model
Progression‐free survival | Overall survival | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age (y) | ||||||
>64.6 | 1.48 | .92‐2.39 | .109 | 1.96 | 1.05‐3.66 | .035 |
CA‐125 | ||||||
≥35 U/mL | 1.89 | .68‐5.23 | .222 | 3.89 | 0.53‐9.99 | .183 |
Paraaortic nodes a | ||||||
Positive | 2.19 | 1.32‐3.64 | .002 | 1.69 | 0.83‐3.43 | .147 |
FIGO stage | ||||||
FIGO IV b | 0.68 | .33‐1.39 | .286 | 0.86 | 0.37‐1.99 | .719 |
Residual disease | ||||||
Yes | 2.44 | 1.23‐4.84 | .011 | 2.17 | 1.11‐4.69 | .028 |
CPLN dimension | ||||||
≥5 mm | 2.92 | 1.38‐6.16 | .005 | 2.43 | 1.12‐5.81 | .019 |
Abbreviations: CI, confidence interval; CPLN, cardiophrenic lymph node; HR, hazard ratio.
Histologically positive paraaortic lymph nodes.
FIGO IIIA‐IIIC vs FIGO IVA and IVB.